ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHA:603976)
China · Delayed Price · Currency is CNY 29.46
-0.39 (-1.31%)
Sep 14, 2026, 3:00 PM CST
SHA:603976 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,486 | 2,923 | 2,449 | 2,980 | 3,107 | 5,159 | |
Market Cap Growth | 44.37% | 19.32% | -17.81% | -4.09% | -39.77% | -53.13% |
Enterprise Value | 4,609 | 3,073 | 2,483 | 3,026 | 3,113 | 4,894 |
Last Close Price | 29.46 | 19.07 | 15.76 | 18.78 | 19.52 | 32.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 247.95 | 154.61 | 46.00 | 74.01 | 47.97 | 48.39 |
Forward PE | - | 29.72 | 29.72 | 29.72 | 29.72 | 29.72 |
PS Ratio | 6.22 | 4.40 | 3.06 | 3.31 | 3.90 | 6.48 |
PB Ratio | 3.75 | 2.42 | 2.00 | 2.45 | 2.62 | 4.43 |
P/TBV Ratio | 3.88 | 2.51 | 2.07 | 2.54 | 2.72 | 4.59 |
P/FCF Ratio | 46.98 | 26.72 | 60.93 | 28.59 | - | - |
P/OCF Ratio | 28.68 | 21.42 | 21.84 | 15.35 | 80.86 | 49.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.39 | 4.63 | 3.10 | 3.36 | 3.91 | 6.14 |
EV/EBITDA Ratio | 33.97 | 23.16 | 13.49 | 19.36 | 20.40 | 26.75 |
EV/EBIT Ratio | 213.23 | 117.02 | 35.64 | 59.48 | 46.80 | 41.99 |
EV/FCF Ratio | 48.27 | 28.09 | 61.77 | 29.03 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.37 | 0.37 | 0.35 | 0.37 | 0.39 | 0.37 |
Debt / EBITDA Ratio | 3.26 | 3.36 | 2.34 | 2.85 | 3.01 | 2.36 |
Debt / FCF Ratio | 4.64 | 4.08 | 10.75 | 4.28 | - | - |
Net Debt / Equity Ratio | 0.10 | -0.03 | 0.15 | 0.01 | 0.08 | -0.18 |
Net Debt / EBITDA Ratio | 0.91 | -0.27 | 0.99 | 0.06 | 0.58 | -1.17 |
Net Debt / FCF Ratio | 1.29 | -0.33 | 4.54 | 0.08 | -0.37 | 6.55 |
Asset Turnover | 0.38 | 0.34 | 0.40 | 0.45 | 0.40 | 0.49 |
Inventory Turnover | 2.76 | 2.31 | 2.93 | 3.73 | 3.22 | 3.50 |
Quick Ratio | 2.69 | 3.66 | 2.29 | 2.22 | 1.92 | 2.51 |
Current Ratio | 3.50 | 4.72 | 3.24 | 2.77 | 2.55 | 3.04 |
Return on Equity (ROE) | 1.43% | 1.56% | 4.37% | 3.36% | 5.51% | 9.66% |
Return on Assets (ROA) | 0.71% | 0.85% | 2.18% | 1.57% | 2.10% | 4.43% |
Return on Invested Capital (ROIC) | 1.55% | 1.92% | 4.69% | 3.66% | 5.98% | 11.12% |
Return on Capital Employed (ROCE) | 1.30% | 1.60% | 4.10% | 3.10% | 4.10% | 7.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.38% | 0.65% | 2.17% | 1.35% | 2.08% | 2.07% |
FCF Yield | 2.13% | 3.74% | 1.64% | 3.50% | -7.65% | -0.63% |
Dividend Yield | 0.84% | 1.52% | 2.20% | 1.06% | 0.31% | 0.96% |
Payout Ratio | 313.42% | 235.32% | 95.17% | 33.09% | 76.65% | 5.82% |
Buyback Yield / Dilution | 6.47% | 4.42% | -2.01% | 0.99% | -0.32% | 0.94% |
Total Shareholder Return | 7.31% | 5.94% | 0.18% | 2.05% | -0.01% | 1.90% |